Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-060739
Filing Date
2026-05-14
Accepted
2026-05-14 08:30:23
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mgtx-20260331x10q.htm   iXBRL 10-Q 2078748
2 EX-10.2 mgtx-20260331xex10d2.htm EX-10.2 44925
3 EX-31.1 mgtx-20260331xex31d1.htm EX-31.1 11321
4 EX-31.2 mgtx-20260331xex31d2.htm EX-31.2 13900
5 EX-32.1 mgtx-20260331xex32d1.htm EX-32.1 6694
6 EX-32.2 mgtx-20260331xex32d2.htm EX-32.2 6702
  Complete submission text file 0001104659-26-060739.txt   8806558

Data Files

Seq Description Document Type Size
7 EX-101.SCH mgtx-20260331.xsd EX-101.SCH 59705
8 EX-101.CAL mgtx-20260331_cal.xml EX-101.CAL 62052
9 EX-101.DEF mgtx-20260331_def.xml EX-101.DEF 253690
10 EX-101.LAB mgtx-20260331_lab.xml EX-101.LAB 475435
11 EX-101.PRE mgtx-20260331_pre.xml EX-101.PRE 426699
78 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20260331x10q_htm.xml XML 1464586
Mailing Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017
Business Address 655 THIRD AVENUE SUITE 1115 NEW YORK NY 10017 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 26975985
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)